Carbonic anhydrase inhibitors: synthesis of Schiff bases of hydroxybenzaldehydes with aromatic sulfonamides and their reactions with arylsulfonyl isocyanates
- PMID: 11140609
- DOI: 10.3109/14756360009040708
Carbonic anhydrase inhibitors: synthesis of Schiff bases of hydroxybenzaldehydes with aromatic sulfonamides and their reactions with arylsulfonyl isocyanates
Abstract
Reaction of o- or p-hydroxybenzaldehydes with sulfanilamide, homosulfanilamide and p-(2-aminoethyl)- benzene-sulfonamide afforded several new Schiff bases which were subsequently derivatized at the phenolic hydroxy moiety by reaction with arylsulfonylisocyanates. The new arylsulfonylcarbamates obtained in this way possessed interesting inhibitory properties against three carbonic anhydrase (CA) isozymes, hCA I, hCA II and bCA IV (h = human, b = bovine isozyme). All these new derivatives, the simple Schiff bases and the arylsulfonylcarbamates obtained as outlined above, were more inhibitory against all isozymes as compared to the corresponding parent sulfonamide from which they were obtained. Generally, the p-hydroxybenzaldehyde derivatives were more active than the corresponding ortho isomers. An interesting behavior was evidenced for some of the ortho-substituted arylsulfonylcarbamato-sulfonamides, which showed higher affinities for the isozyme hCA I, as compared to hCA II and bCA IV (generally hCA I is 10-1000 less sensitive to "normal" sulfonamide inhibitors, such as acetazolamide, methazolamide or dorzolamide, as compared to hCA II). This make the new derivatives attractive leads for designing isozyme I-specific inhibitors.
Similar articles
-
Carbonic anhydrase inhibitors. Schiff bases of some aromatic sulfonamides and their metal complexes: towards more selective inhibitors of carbonic anhydrase isozyme IV.J Enzyme Inhib. 1999;14(6):407-23. doi: 10.3109/14756369909030332. J Enzyme Inhib. 1999. PMID: 10536875
-
Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.Bioorg Med Chem Lett. 2005 Jun 15;15(12):3096-101. doi: 10.1016/j.bmcl.2005.04.055. Bioorg Med Chem Lett. 2005. PMID: 15908204
-
Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors.Bioorg Med Chem. 2017 Jun 15;25(12):3093-3097. doi: 10.1016/j.bmc.2017.03.063. Epub 2017 Mar 31. Bioorg Med Chem. 2017. PMID: 28400084
-
Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.Bioorg Med Chem. 2016 Mar 1;24(5):982-8. doi: 10.1016/j.bmc.2016.01.020. Epub 2016 Jan 11. Bioorg Med Chem. 2016. PMID: 26803577
-
Recent Advances in Biological Active Sulfonamide based Hybrid Compounds Part A: Two-Component Sulfonamide Hybrids.Curr Med Chem. 2023;30(4):407-480. doi: 10.2174/0929867329666220622153348. Curr Med Chem. 2023. PMID: 35733317 Review.
Cited by
-
Design, synthesis, molecular modeling, and biological evaluation of sulfanilamide-imines derivatives as potential anticancer agents.Naunyn Schmiedebergs Arch Pharmacol. 2013 Sep;386(9):813-22. doi: 10.1007/s00210-013-0883-y. Epub 2013 May 26. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23708566 Free PMC article.